These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20856833)

  • 21. Gene-based continuous expression of FVIIa for the treatment of hemophilia.
    Margaritis P
    Front Biosci (Schol Ed); 2012 Jan; 4(1):287-99. PubMed ID: 22202061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
    Margaritis P; Arruda VR; Aljamali M; Camire RM; Schlachterman A; High KA
    J Clin Invest; 2004 Apr; 113(7):1025-31. PubMed ID: 15057309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
    Nogami K; Matsumoto T; Yada K; Ogiwara K; Furukawa S; Shida Y; Takeyama M; Shima M
    Br J Haematol; 2018 May; 181(4):528-536. PubMed ID: 29611182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets.
    Ohmori T; Ishiwata A; Kashiwakura Y; Madoiwa S; Mitomo K; Suzuki H; Hasegawa M; Mimuro J; Sakata Y
    Mol Ther; 2008 Aug; 16(8):1359-65. PubMed ID: 18523449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
    Keshava S; Sundaram J; Rajulapati A; Pendurthi UR; Rao LV
    J Thromb Haemost; 2016 Mar; 14(3):546-50. PubMed ID: 26727350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.
    Turecek PL; Bossard MJ; Graninger M; Gritsch H; Höllriegl W; Kaliwoda M; Matthiessen P; Mitterer A; Muchitsch EM; Purtscher M; Rottensteiner H; Schiviz A; Schrenk G; Siekmann J; Varadi K; Riley T; Ehrlich HJ; Schwarz HP; Scheiflinger F
    Hamostaseologie; 2012; 32 Suppl 1():S29-38. PubMed ID: 22961422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A.
    Martinowitz U; Lalezari S; Luboshitz J; Lubetsky A; Spira J
    Haemophilia; 2008 Sep; 14(5):1122-4. PubMed ID: 18564190
    [No Abstract]   [Full Text] [Related]  

  • 29. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
    Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
    J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma-derived factors VIIa and X mixtures (Byclot
    Ochi S; Takeyama M; Shima M; Nogami K
    Int J Hematol; 2020 Jun; 111(6):779-785. PubMed ID: 32030609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
    Shetty KA; Kosloski MP; Mager DE; Balu-Iyer SV
    Biopharm Drug Dispos; 2016 Oct; 37(7):409-420. PubMed ID: 27418232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac tamponade in a patient with moderate hemophilia A and factor VIII Inhibitors.
    Ghosh N; Teefy P; Laudenbach L; Rivard GE
    Can J Cardiol; 2006 Jan; 22(1):73-5. PubMed ID: 16450022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.
    Ramani K; Miclea RD; Purohit VS; Mager DE; Straubinger RM; Balu-Iyer SV
    J Pharm Sci; 2008 Apr; 97(4):1386-98. PubMed ID: 17705286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
    Rea CJ; Foley JH; Bevan DH; Sørensen B
    Ann Hematol; 2014 Apr; 93(4):683-92. PubMed ID: 24193375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
    Bhat V; von Drygalski A; Gale AJ; Griffin JH; Mosnier LO
    Thromb Haemost; 2016 Mar; 115(3):551-61. PubMed ID: 26466980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
    Augustsson C; Persson E
    Blood; 2014 Nov; 124(20):3172-4. PubMed ID: 25232061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure of FVIII in the Presence of Phosphatidyl Serine Reduces Generation of Memory B-Cells and Induces Regulatory T-Cell-Mediated Hyporesponsiveness in Hemophilia A Mice.
    Ramakrishnan R; Davidowitz A; Balu-Iyer SV
    J Pharm Sci; 2015 Aug; 104(8):2451-6. PubMed ID: 26038127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longer-acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue.
    Di Minno G; Cerbone AM; Coppola A; Cimino E; Di Capua M; Pamparana F; Tufano A; Di Minno MN
    Haemophilia; 2010 Jan; 16 Suppl 1():2-6. PubMed ID: 20059562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A.
    Konkle BA; Stasyshyn O; Chowdary P; Bevan DH; Mant T; Shima M; Engl W; Dyck-Jones J; Fuerlinger M; Patrone L; Ewenstein B; Abbuehl B
    Blood; 2015 Aug; 126(9):1078-85. PubMed ID: 26157075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.